Utility of LDH-A in the differentiation between lymphocytic pleural effusions of malignantand non-malignant etiology

N. Piskac Živkovic (Zagreb, Croatia), L. Malnar (Zagreb, Croatia), I. Kovacevic (Zagreb, Croatia)

Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Session: Novel directions in pleural disease: bench to bedside
Session type: E-poster session
Number: 1132
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Piskac Živkovic (Zagreb, Croatia), L. Malnar (Zagreb, Croatia), I. Kovacevic (Zagreb, Croatia). Utility of LDH-A in the differentiation between lymphocytic pleural effusions of malignantand non-malignant etiology. 1132

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The value of IL6 in differentiation between malignant and non malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011



Differentiating tuberculous pleuritis from other exudative lymphocytic pleural effusions
Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Year: 2018


Management of malignant pleural effusions
Source: Eur Respir J 2001; 18: 402-419
Year: 2001


Management of malignant pleural effusions
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019

Management of malignant pleural effusions
Source: Guideline 2001
Year: 2001

Separating malignant from nonmalignant pleural effusion on the basis of PO2 in pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 541s
Year: 2003

Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012

Comparison of telomerase activity in malignant and benign pleural effusions
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011

Management of recurrent malignant pleural effusions
Source: ERS Skills Course 2018 - Thoracoscopy and pleural techniques
Year: 2018

Management of recurrent malignant pleural effusions
Source: ERS Skills Course 2016 - Thoracoscopy and pleural techniques
Year: 2016

Management of recurrent malignant pleural effusions
Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques, April 2019
Year: 2019

Management of recurrent malignant pleural effusions
Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques
Year: 2019

Management of recurrent malignant pleural effusions
Source: ERS Skills Course 2017 - Thoracoscopy and Pleural Techniques
Year: 2017

Management of recurrent malignant pleural effusions
Source: ERS Skills Course 2016
Year: 2016

Diagnostic implications of telomerase activity in pleural effusions
Source: Eur Respir J 2003; 22: 422-426
Year: 2003



Usfulness of cholesterol in difering malignant and nonmalignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 246s
Year: 2004

Management of malignant pleural effusion
Source: Eur Respir J 2001; 18: Suppl. 33, 397s
Year: 2001